Ranbaxy Confirms 'Global' Deal Resolving Antitrust MDL
Parties in a multidistrict lawsuit against Ranbaxy Pharmaceuticals told a Boston federal judge Thursday to release their precious month of trial time after confirming that the company reached a $485 million...To view the full article, register now.
Already a subscriber? Click here to view full article